本文選題：參桂護(hù)心湯　切入點(diǎn)：冠心病房顫　出處：《黑龍江中醫(yī)藥大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：目的通過觀察參桂護(hù)心湯治療冠心病房顫(心陽不振證)患者的臨床療效及對生活質(zhì)量的影響,探討參桂護(hù)心湯治療冠心病房顫(心陽不振證)的有效性。方法本研究通過選擇2016年03月～2016年12月在黑龍江中醫(yī)藥大學(xué)附屬第一醫(yī)院心內(nèi)一科門診患者,診斷適合納入標(biāo)準(zhǔn)的患者60例。隨機(jī)將60例患者分為對照組及治療組,對照組:西醫(yī)基礎(chǔ)治療加鹽酸地爾硫卓緩釋膠囊,90mg,1次/日,口服;治療組:對照組基礎(chǔ)上加參桂護(hù)心湯,150ml/次,早飯前晚飯后日2次口服,各30例,服藥療程均為1個月。對比兩組治療前后生活質(zhì)量、心室率、中醫(yī)證候積分、中醫(yī)癥狀療效的變化。結(jié)果1.生活質(zhì)量變化:治療組用藥前后具有統(tǒng)計學(xué)意義(P0.01),對照組用藥前后具有統(tǒng)計學(xué)意義(P0.05),兩組別組間比較具有統(tǒng)計學(xué)意義(P0.01),治療組變化明顯優(yōu)于對照組。2.心室率變化:治療組用藥前后具有統(tǒng)計學(xué)意義(P0.01),對照組用藥前后具有統(tǒng)計學(xué)意義(P＜0.05),兩組別組間對比具有統(tǒng)計學(xué)意義(P0.01),治療組變化明顯優(yōu)于對照組。3.中醫(yī)證候積分改變:治療組用藥前后具有統(tǒng)計學(xué)意義(P0.05),對照組用藥前后具有統(tǒng)計學(xué)意義(P0.05),兩組別組間比較具有統(tǒng)計學(xué)意義(P0.05),治療組變化明顯優(yōu)于對照組。4.中醫(yī)癥狀療效改變:治療組用藥前后具有統(tǒng)計學(xué)意義(P0.05),對照組用藥前后具有統(tǒng)計學(xué)意義(P0.05),兩組別組間比較具有統(tǒng)計學(xué)意義(P0.05),治療組變化明顯優(yōu)于對照組。結(jié)論1、參桂護(hù)心湯能夠提高冠心病房顫(心陽不振證)患者的生活質(zhì)量;2、參桂護(hù)心湯能夠降低冠心病房顫(心陽不振證)患者的心室率;3、參桂護(hù)心湯能夠改善冠心病房顫(心陽不振證)患者的中醫(yī)證候積分、中醫(yī)癥候表現(xiàn)。
[Abstract]:Objective to observe the clinical effect of Shengui Huxin decoction in treating coronary heart disease (CHD) patients with atrial fibrillation (XYD) and its effect on quality of life (QOL). To explore the efficacy of Shengui Huxin decoction in the treatment of atrial fibrillation of coronary heart disease (heart yang failure syndrome). Methods from March 2016 to December 2016 in Heilongjiang University of traditional Chinese Medicine, the patients were selected from the first affiliated Hospital of Heilongjiang University of traditional Chinese Medicine. 60 patients were randomly divided into control group and treatment group. The control group was treated with basic western medicine and diltiazem hydrochloride sustained-release capsule 90 mg / d orally. The treatment group: the control group was treated with Shengui Huxin decoction 150 ml / time, and 30 cases were taken orally before and after breakfast, 30 cases were treated for 1 month. The quality of life, ventricular rate and TCM syndrome score were compared before and after treatment. Results 1. Quality of life: the treatment group had statistical significance before and after treatment, the control group had statistical significance before and after treatment, the comparison between the two groups had statistical significance P0.01, the treatment group had the change. The change of ventricular rate in the treatment group was significantly better than that in the control group (P < 0.05). The changes of ventricular rate in the treatment group were significantly better than those in the control group (P < 0.05). The changes in the treatment group were significantly better than those in the control group (P < 0.05). Group 3. Changes of TCM syndromes integral: the treatment group had statistical significance before and after medication, the control group had statistical significance before and after medication, and the comparison between the two groups had statistical significance. The change of the treatment group was obviously better than that of the control group. The change of the curative effect of medical symptoms: the treatment group had statistical significance before and after treatment, the control group had statistical significance before and after treatment, and the comparison between the two groups had statistical significance. The change of the treatment group was obviously better than that of the control group. Gui Huxin decoction can improve the quality of life of patients with coronary heart disease atrial fibrillation (Xinyang failure syndrome), Shen Gui Huxin decoction can reduce the ventricular rate of coronary heart disease patients with atrial fibrillation (heart Yang failure syndrome), and Shengui Huxin decoction can improve coronary heart disease atrial fibrillation. Syndrome integral of traditional Chinese Medicine (TCM) in patients with Heart Yang failure Syndrome, Symptoms of TCM.
【學(xué)位授予單位】：黑龍江中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R259

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 馬長生;;房顫的流行病學(xué)進(jìn)展[J];醫(yī)學(xué)與哲學(xué)(B);2016年11期

2 段文慧;史大卓;;從“風(fēng)邪”致病談陣發(fā)性房顫的中醫(yī)臨床治療[J];中西醫(yī)結(jié)合心腦血管病雜志;2015年13期

3 孫寧玲;霍勇;葛均波;陳魯原;馮穎青;楊艷敏;嚴(yán)曉偉;廖玉華;顧曄;荊珊;;非二氫吡啶類鈣拮抗劑在心血管疾病中應(yīng)用的專家建議[J];中華高血壓雜志;2015年03期

4 張利;;甘草的藥理作用及現(xiàn)代研究進(jìn)展[J];中醫(yī)臨床研究;2014年10期

5 王永霞;原雙興;;桂枝甘草湯治療心律失常現(xiàn)狀探討[J];中華中醫(yī)藥雜志;2013年02期

6 林輝;徐大量;陳麗敏;張鵬;;桂枝甘草湯乙酸乙酯萃取部位的藥效學(xué)研究[J];中藥新藥與臨床藥理;2013年01期

7 于學(xué)康;;麥冬的藥理作用研究進(jìn)展[J];天津藥學(xué);2012年04期

8 付麗;劉小慧;;住院房顫患者伴焦慮抑郁對生活質(zhì)量的影響[J];中國心血管病研究;2012年08期

9 楊繼媛;吳紅金;吳德琳;;甘草次酸對大鼠心室肌細(xì)胞鈉離子通道電流的影響[J];中國中西醫(yī)結(jié)合雜志;2012年07期

10 馮善濤;李立煌;任利;;桂枝甘草湯對心陽虛心動過緩大鼠竇房結(jié)Gsα蛋白含量的影響[J];亞太傳統(tǒng)醫(yī)藥;2012年01期

，

本文編號：1626283